
Cerenome, Inc.
CNSYHealthcare|Medical - Pharmaceuticals|US
$0.64
-0.03 (-4.06%)
DCF Value
$2.01
Tangible Book / Share
$0.71
Cash / Share
$1.27
Ownership Breakdown
7.6M
Shares Outstanding
6.8M
Float Shares
Insider Trades (22)
Last 4 quarters: 24,029 acquired · 24,029 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| van Es-Johansson An | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |
| van Es-Johansson An | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |
| Hawkins Richard J | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |
| Hawkins Richard J | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |
| Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Oct 1, 2026 | OPTION EX. | 1,533 | — | — | Form 4 |
| Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Oct 1, 2026 | OPTION EX. | 1,165 | — | — | Form 4 |
| Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Oct 1, 2026 | OPTION EX. | 287 | — | — | Form 4 |
| Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Oct 1, 2026 | OPTION EX. | 287 | — | — | Form 4 |
| Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Oct 1, 2026 | OPTION EX. | 1,165 | — | — | Form 4 |
| Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Oct 1, 2026 | OPTION EX. | 1,533 | — | — | Form 4 |
| Clowes Howard | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |
| Clowes Howard | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |
| HEDRICK MARC H | director, officer: Chief Executive Officer | Oct 1, 2026 | OPTION EX. | 6,387 | — | — | Form 4 |
| HEDRICK MARC H | director, officer: Chief Executive Officer | Oct 1, 2026 | OPTION EX. | 8,066 | — | — | Form 4 |
| HEDRICK MARC H | director, officer: Chief Executive Officer | Oct 1, 2026 | OPTION EX. | 1,986 | — | — | Form 4 |
| HEDRICK MARC H | director, officer: Chief Executive Officer | Oct 1, 2026 | OPTION EX. | 1,986 | — | — | Form 4 |
| HEDRICK MARC H | director, officer: Chief Executive Officer | Oct 1, 2026 | OPTION EX. | 8,066 | — | — | Form 4 |
| HEDRICK MARC H | director, officer: Chief Executive Officer | Oct 1, 2026 | OPTION EX. | 6,387 | — | — | Form 4 |
| ANDREWS RONALD ASBURY | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |
| ANDREWS RONALD ASBURY | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |
| Guse Kyle | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |
| Guse Kyle | director | Oct 1, 2026 | OPTION EX. | 921 | — | — | Form 4 |